Compare NBRG & FLNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBRG | FLNA |
|---|---|---|
| Founded | 2021 | 1998 |
| Country | Hong Kong | United States |
| Employees | N/A | 20 |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.3M | 61.8M |
| IPO Year | 2026 | N/A |
| Metric | NBRG | FLNA |
|---|---|---|
| Price | $9.97 | $0.98 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.6K | ★ 343.5K |
| Earning Date | N/A | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.59 | $0.86 |
| 52 Week High | $10.00 | $2.03 |
| Indicator | NBRG | FLNA |
|---|---|---|
| Relative Strength Index (RSI) | 53.22 | 40.36 |
| Support Level | $9.96 | $0.86 |
| Resistance Level | $9.99 | $1.37 |
| Average True Range (ATR) | 0.00 | 0.05 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 25.00 | 48.76 |
Newbridge Acquisition Ltd is a blank check company.
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.